<DOC>
	<DOCNO>NCT03052296</DOCNO>
	<brief_summary>The purpose BIOLUX P-III Spain registry investigate safety clinical performance Passeo-18 Lux Drug Coated Balloon treatment long atherosclerotic femoropoliteal artery lesion daily clinical practice</brief_summary>
	<brief_title>BIOLUX P-III SPAIN All-Comers Registry</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Age ≥ 18 year minimum age require local regulation Subject must willing sign Patient Data Release Form ( PDRF ) Patient Informed Consent ( PIC ) applicable Subject classify Rutherford class 4 , 5 6 TASC C D lesion ( ) femoropopliteal artery Lesion length &gt; 15 cm suitable endovascular treatment treat schedule treated Passeo18 Lux drug release balloon Life expectancy ≤ 1 year Subject currently participate another investigational drug device study reach primary endpoint yet . Subject pregnant planning become pregnant course study . Rutherford class &lt; 4 Failure successfully cross target lesion guide wire ( successful crossing mean tip guide wire distal target lesion absence flow limit dissection perforation ) . Intraprocedural decision proceed Passeo18 Lux DCB reason related device ( instance blood flow limit dissection predilatation ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>